Skip to content

Clinical trials

Phase 1 Obesity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 1 Country / region: United States Clear all

358 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20034
20043
20058
20067
200711
200811
200915
20109
20118
201211
201318
201411
20156
201616
201712
201820
201911
202012
20219
202218
202323
202437
202538
202637

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed247
Recruiting45
Active, not recruiting22
Terminated18
Withdrawn11
Not yet recruiting6
Unknown status6
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S42
Eli Lilly and Company32
Pfizer24
Mayo Clinic15
Amgen13
AstraZeneca11
Columbia University8
Massachusetts General Hospital7
Vanderbilt University Medical Center7
Yale University7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity358
Overweight113
Diabetes Mellitus, Type 235
Insulin Resistance29
Diabetes Mellitus18
Nutrition Disorders18
Weight Loss15
Hypertension14
Non-alcoholic Fatty Liver Disease13
Cardiovascular Diseases9

Trials

Showing 1 to 25 of 358. Each trial links to its page on Pharma Observatory.

258 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.